Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (15 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Research and development
3
4
5
7
6
5
General and administrative
1
3
4
4
4
3
Restructuring costs
0
0
0
1
0
0
Merger costs
0
1
0
0
0
0
Total costs and expenses
4
7
9
12
10
9
Loss from operations
-4
-7
-9
-12
-10
-9
Grant income
0
0
0
0
0
0
Gain on revaluation of derivative warrants
0
0
0
2
2
4
Loss on issuance of derivative warrants
0
0
0
-1
0
0
Interest expense, net
-1
0
0
0
0
0
Other income
0
0
0
0
0
0
Total other income, net
0
0
0
2
2
3
Net loss
-5
-7
-9
-11
-8
-5
DEEMED DIVIDEND ON WARRANTS
0
0
-1
0
0
0
Net loss attributable to common stockholders
0
-7
-9
0
0
0
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 28, 2013 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on May 20, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (29 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
1
6
5
2
9
4
Restricted cash
1
0
0
0
0
0
Prepaid expenses and other current assets
0
0
0
0
0
0
Deferred financing
0
0
0
0
0
0
Total current assets
1
6
5
3
10
4
Restricted cash
0
0
2
0
0
0
Fixed Assets, net
4
3
3
2
2
2
Goodwill
0
2
2
2
2
2
Other assets
0
0
0
0
0
0
Total assets
5
11
11
7
13
8
Liabilities and owners' equity
Current maturities of notes payable
0 204802
0 0
0 0
0 0
0 119923
0 243590
Accounts payable and accrued liabilities
0 392881
0 478041
1 716990
1 1162098
1 933988
1 675924
Accrued interest
0 305049
0 0
0 0
0 0
0 0
0 0
Derivative liability
0 0
0 23305
0 13304
3 3359363
5 5176915
5 4781082
Capital lease obligations, current portion
0 2085
0 2235
0 2397
0 1694
0 2180
0 2449
Total current liabilities
1 904817
1 503581
1 732691
5 4523155
6 6233006
6 5703045
Convertible debt
3 2720985
0 0
0 0
0 0
0 0
0 0
Notes payable, less current maturities
1 920941
0 450000
0 450000
0 450000
0 330077
0 86632
Deferred rent
0 115311
0 124381
0 135404
0 143234
0 147774
0 148924
Capital lease obligations, less current portion
0 6326
0 4091
0 1694
0 0
0 11126
0 7975
Total long-term liabilities
4 3763563
1 578472
1 587098
1 593234
0 488977
0 243531
Total liabilities
0 0
0 0
1 1319789
5 5116389
7 6721983
6 5946576
Commitments and contingencies (Notes 12 and 13)
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock, $0.00001 par value; 7,000 shares authorized; none issued and outstanding as of December 31, 2015 and 2014
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, $0.00001 par value; 40,000,000 shares authorized; 858,140 and 756,276 shares issued and outstanding at December 31, 2015 and 2014, respectively
0 128
0 369
0 464
0 29
0 8
0 9
Additional paid-in capital
24 24178638
41 40961180
50 50435311
53 52759089
66 65809195
66 66256494
Accumulated deficit
-24 -24045004
-31 -31480426
-40 -40277400
-51 -51059568
-59 -59111670
-65 -64606700
Total stockholders’ equity
0 133762
9 9481123
10 10158375
2 1699550
7 6697533
2 1649803
Total liabilities and stockholders’ equity
5 4802142
11 10563176
11 11478164
7 6815939
13 13419516
8 7596379
Remarks restated on Nov 30, -1 n/a restated on Mar 28, 2013 n/a restated on Mar 19, 2014 n/a restated on May 20, 2015 n/a restated on Mar 11, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (38 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net loss
-5
-7
-9
-11
-8
-5
Depreciation and amortization
1
1
0
0
0
0
Stock-based compensation
0
1
2
2
1
0
Intrinsic value of beneficial conversion feature associated with convertible debt
0
0
0
0
0
0
Issuance of stock for technology and services
0
0
0
0
0
0
Impairment of intangible assets
0
0
0
0
0
0
Non-cash interest expense related to convertible debt
0
0
0
0
0
0
Loss on disposal of fixed assets
0
0
0
0
0
0
Gain on revaluation of derivative warrants
0
0
0
-2
-2
-4
Loss on issuance of derivative warrants
0
0
0
1
0
0
Prepaid expenses and other current assets
0
0
0
0
0
0
Accounts payable and accrued liabilities
0
0
0
0
0
0
Accrued interest
0
0
0
0
0
0
Deferred rent
0
0
0
0
0
0
Cash used in operating activities
-3
-6
-7
-9
-9
-8
Cash acquired in a business combination
0
1
0
0
0
0
Purchases of fixed assets
0
0
0
0
0
0
Proceeds from sale of fixed assets
0
0
0
0
0
0
Purchases of short-term certificates of deposit
0
0
0
0
0
0
Proceeds from short-term certificates of deposit
0
0
0
0
0
0
Change in restricted cash
0
1
-2
2
0
0
Payment for intangible assets
0
0
0
0
0
0
Cash used in investing activities
0
1
-2
2
0
0
Cash paid for issuance costs
0
0
0
0
-1
0
Proceeds from issuance of convertible notes
3
0
0
0
4
0
Proceeds from issuance of notes payable
0
0
0
0
1
0
Payment of notes payable
0
0
0
0
-1
0
Payments on capital lease obligations
0
0
0
0
0
0
Reverse stock split fractional shares
0
0
0
0
0
0
Proceeds from issuance of common stock and warrants
0
10
7
5
12
3
Proceeds from exercise of warrant
0
0
1
0
0
0
Repurchase of common stock
0
0
0
0
0
0
Cash in lieu of fractional shares in a business combination
0
0
0
0
0
0
Payments on long-term obligations
0
-1
0
0
0
0
Deferred financing costs
0
0
0
0
0
0
Cash provided by financing activities
3
10
8
5
16
3
Increase (decrease) in cash and cash equivalents
0
5
-1
-2
7
-6
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 28, 2013 n/a
calculated values,
restated on Mar 19, 2014 n/a
calculated values,
restated on May 20, 2015 n/a
calculated values,
restated on Mar 11, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,